Exagen Inc. (XGN)

USD 4.6

(7.98%)

Long Term Debt Summary of Exagen Inc.

  • Exagen Inc.'s latest annual long term debt in 2023 was 19.23 Million USD , down -42.2% from previous year.
  • Exagen Inc.'s latest quarterly long term debt in 2024 Q2 was 19.83 Million USD , up 2.91% from previous quarter.
  • Exagen Inc. reported annual long term debt of 33.27 Million USD in 2022, up 21.08% from previous year.
  • Exagen Inc. reported annual long term debt of 27.47 Million USD in 2021, up 3.07% from previous year.
  • Exagen Inc. reported quarterly long term debt of 19.83 Million USD for 2024 Q2, up 2.91% from previous quarter.
  • Exagen Inc. reported quarterly long term debt of 19.23 Million USD for 2023 Q4, down -15.73% from previous quarter.

Annual Long Term Debt Chart of Exagen Inc. (2023 - 2012)

Historical Annual Long Term Debt of Exagen Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 19.23 Million USD -42.2%
2022 33.27 Million USD 21.08%
2021 27.47 Million USD 3.07%
2020 26.65 Million USD 3.11%
2019 25.85 Million USD 5.02%
2018 24.61 Million USD 30.88%
2017 18.8 Million USD 0.0%
2015 487 Thousand USD -66.67%
2014 1.46 Million USD 0.0%
2013 - USD -100.0%
2012 1.37 Million USD 0.0%

Peer Long Term Debt Comparison of Exagen Inc.

Name Long Term Debt Long Term Debt Difference
Aspira Women's Health Inc. 1.43 Million USD -1244.825%
bioAffinity Technologies, Inc. 1.11 Million USD -1619.405%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -23547.386%
Standard BioTools Inc. 3.98 Million USD -382.827%
Inotiv, Inc. 399.4 Million USD 95.185%
Prenetics Global Limited 867.21 Thousand USD -2117.559%
Neuronetics, Inc. 59.28 Million USD 67.561%
Star Equity Holdings, Inc. 1.14 Million USD -1579.563%
Castle Biosciences, Inc. 14.19 Million USD -35.449%
Psychemedics Corporation 945 Thousand USD -1935.026%
RadNet, Inc. 812.06 Million USD 97.632%
Exact Sciences Corporation 2.47 Billion USD 99.223%
IDEXX Laboratories, Inc. 622.88 Million USD 96.913%
iSpecimen Inc. 29.13 Thousand USD -65917.851%
OpGen, Inc. 2.02 Million USD -851.269%
Bionano Genomics, Inc. 7.17 Million USD -168.028%
CareDx, Inc 28.27 Million USD 31.993%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 75.71%
Guardant Health, Inc. 1.13 Billion USD 98.313%
Biodesix, Inc. 35.22 Million USD 45.405%
BioNexus Gene Lab Corp. 98.76 Thousand USD -19371.867%
Precipio, Inc. 106 Thousand USD -18042.453%
Natera, Inc. 282.94 Million USD 93.203%
Fulgent Genetics, Inc. 10.11 Million USD -90.199%
Sera Prognostics, Inc. 840 Thousand USD -2189.405%
23andMe Holding Co. 67.84 Million USD 71.655%
OPKO Health, Inc. 222.03 Million USD 91.339%
Personalis, Inc. 1.23 Million USD -1458.428%
Aclaris Therapeutics, Inc. 3.07 Million USD -525.602%
Applied DNA Sciences, Inc. 739.16 Thousand USD -2501.73%
T2 Biosystems, Inc. 6.59 Million USD -191.467%
Neogen Corporation 888.39 Million USD 97.835%
Myriad Genetics, Inc. 130.9 Million USD 85.309%
ICON Public Limited Company 3.66 Billion USD 99.475%
NeoGenomics, Inc. 606.06 Million USD 96.827%
Star Equity Holdings, Inc. 1.14 Million USD -1579.563%
MDxHealth SA 35.56 Million USD 45.926%
Prenetics Global Limited 867.21 Thousand USD -2117.559%
Illumina, Inc. 1.48 Billion USD 98.708%
DarioHealth Corp. 24.59 Million USD 21.797%
ENDRA Life Sciences Inc. 192.06 Thousand USD -9912.912%
Medpace Holdings, Inc. 142.12 Million USD 86.469%
Mainz Biomed B.V. 2.19 Million USD -775.773%
Trinity Biotech plc 54.65 Million USD 64.811%
Sotera Health Company 2.22 Billion USD 99.135%
bioAffinity Technologies, Inc. 1.11 Million USD -1619.405%